Where does Horizon Therapeutics, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Horizon Therapeutics, LLC ranks #14,668 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Horizon Therapeutics, LLC hold?

Horizon Therapeutics, LLC holds 20 US utility patents granted between 2015 and 2021, spanning 5 technology areas.

What is Horizon Therapeutics, LLC's Innovation Score?

Horizon Therapeutics, LLC has an Innovation Score of 24.4 out of 100 (15th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Horizon Therapeutics, LLC focus on?

Horizon Therapeutics, LLC's top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 17 patents, ranking #897 of 7,863 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Horizon Therapeutics, LLC's patent grant rate increasing or decreasing?

Horizon Therapeutics, LLC's recent grant velocity is -82% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Horizon Therapeutics, LLC's patents?

Horizon Therapeutics, LLC's patents average 10.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Horizon Therapeutics, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Horizon Therapeutics, LLC

USPTO PatentsView assignee record - 20 granted patents across 5 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Horizon ranks #14,668 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 5 technology areas.

#14,668
of 49,997 US assignees by volume: 15th percentile
by Innovation Score (24.4/100): 10.0
avg claims per patent: -82%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14668 · US Corporation #14,668 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 20 grants
MID-PACK #14,668/49,997
PHOTO-FINISH Habasit
CPC-NARROW G01N · 5 areas
INNOV-THIN 24.4/100
CLAIMS-PAR 10.0 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -82% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Habasit AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Horizon’s 24.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (43%) Velocity 0.0 pts (0%) Breadth 7.9 pts (32%) Claim depth 6.0 pts (25%)

Qualcomm Incorporated · highest

85
Horizon Therapeutics · this assignee

24
3D Lighting… · lowest

7

What this shows Horizon's Innovation Score is 24.4/100 (15th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Horizon?

Each dot is one of Horizon’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Horizon’s own 10.0 claims/patent is at or below the 15.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Horizon vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Horizon's grants concentrate

Horizon Therapeutics, LLC is a focused PatentsView assignee: 5 CPC subclasses with 85% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2018 (6 grants) versus a trough of 1 in 2015. By volume, Horizon sits between Habasit AG and IGM Biosciences, Inc..

Habasit

20
Hangzhou Hikrobot…

20
Harbin Institute…

20
Holland

20
Horsch Maschinen

20
Hydrafacial

20
IAV Ingenieurgese…

20
IGM Biosciences

20
Horizon Therapeut… ◀

20

What this shows Horizon holds 20 patents at rank #14,670, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Horizon

By rank, the assignees closest to #14,670 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Horizon's primary technology class.

Horizon's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

24 15th percentile higher than 15% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Horizon Therapeutics, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	5.0%
2016	3	15.0%
2017	1	5.0%
2018	6	30.0%
2019	6	30.0%
2020	2	10.0%
2021	1	5.0%

Which technologies does Horizon Therapeutics, LLC patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 17

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 17

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 16

Y10T - Technical Subjects Covered BY Former US Classification 14

C07C - Acyclic OR Carbocyclic Compounds 3

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Horizon Therapeutics, LLC's patent record in context - here's where to go next.

Horizon Therapeutics, LLC's lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 85% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #14,668 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Horizon Therapeutics, LLC against Habasit AG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 24.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.